Furthermore, the ratio of specific GPR137 isoforms varied in tumor versus normal intestinal human samples, and expression of a specific ESRP1-dependent GPR137 isoform predicted CRC patient survival. This evidence concerns the gene GPR137 and colorectal carcinoma.